DEINOVE Email Format

Biotechnology ResearchOccitanie, France51-200 Employees

DEINOVE is a French biotechnology company focused on exploring a largely untapped microbial domain to uncover metabolic potential in rare bacteria, including those that are difficult to culture. Its work aims to address antimicrobial resistance by discovering and developing new therapies—antibiotics, antifungals, antivirals, and antiparasitics—targeting superbugs that cause severe infections. The company has built a specialized platform and a large collection of bacterial strains and extracts, which it leverages across multiple development programs, including a Phase II antibiotic candidate for severe Clostridioides difficile infections. In addition to therapeutic development, DEINOVE has developed bacterial micro-factories intended to enable industrial production of complex, rare compounds that are difficult to synthesize chemically. Based in Montpellier, the company operates within the biotechnology research sector and collaborates with a network of academic, technological, industrial, and institutional partners.

Sign up for free to view info

Company overview Employee directory